Solubility Enhancement

PRESS RELEASE October 8, 2025, Asahi Kasei Corp. - Asahi Kasei, a trusted provider in healthcare materials and technology, announced...

Abstract Lornoxicam, a potent nonsteroidal anti-inflammatory drug (NSAID), suffers from poor aqueous solubility, leading to limited dissolution and variable bioavailability....

Abstract Uveitis is an ocular inflammatory condition that can be infectious or non-infectious, affecting various ocular structures. Corticosteroids and immunomodulators...

Abstract Pulmonary delivery can deliver cannabidiol (CBD) with high bioavailability and fast onset of action. One formulation obstacle is the...

Zerion Pharma Zerion is a pharmaceutical development company aspiring to transform the pharmaceutical landscape with a new formulation technology, Dispersome®, that...

Summary Ritonavir (RTV) is an anti-HIV protease inhibitor and antiretroviral medication to treat HIV /AIDS and especially COVID-19 infection. But...

Abstract Proteolysis targeting chimeras (PROTACs) are heterobifunctional degraders with a unique mode of action that permits access to “undruggable” targets....

A technology based on a natural, biodegradable excipient The Dispersome® technology uses high quality whey protein, an environmentally friendly by-product from cheese...

Abstract The oral bioavailability and therapeutic efficacy of a compound are largely determined by its aqueous solubility and interfacial partitioning....

Dispersome is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions...